*/
Extending the fixed costs regime is the only way to bring down civil litigation costs, according to Lord Justice Jackson.
The architect of the present civil costs regime reiterated his call for fixed recoverable costs to be extended from personal injury claims to all cases up to £250,000.
He told a conference organised by the Westminster Legal Policy Forum in May that extending the fixed costs regime for all remaining fast-track cases was ‘unfinished business’ that needed to be addressed as soon as possible.
He said: ‘I do ask you to accept that the only way to control costs is to do so in advance. That will mean that each side will know what they have to pay out if they lose, and what they get back if they win.’
He suggested this could be achieved through either a grid setting cost rates for different cases or having a budget tailored to individual kinds of case.
Jackson said he hoped ‘serious consideration’ would be given to the fast and multi-track regimes.
Meanwhile, ministers took the decision temporarily to delay controversial plans to impose fixed costs in clinical negligence claims up to £250,000. The scheme was due to come into force on 1 October.
But health minister Ben Gummer confirmed that the implementation would not go ahead as planned and that a consultation will be published later in the year.
Extending the fixed costs regime is the only way to bring down civil litigation costs, according to Lord Justice Jackson.
The architect of the present civil costs regime reiterated his call for fixed recoverable costs to be extended from personal injury claims to all cases up to £250,000.
He told a conference organised by the Westminster Legal Policy Forum in May that extending the fixed costs regime for all remaining fast-track cases was ‘unfinished business’ that needed to be addressed as soon as possible.
He said: ‘I do ask you to accept that the only way to control costs is to do so in advance. That will mean that each side will know what they have to pay out if they lose, and what they get back if they win.’
He suggested this could be achieved through either a grid setting cost rates for different cases or having a budget tailored to individual kinds of case.
Jackson said he hoped ‘serious consideration’ would be given to the fast and multi-track regimes.
Meanwhile, ministers took the decision temporarily to delay controversial plans to impose fixed costs in clinical negligence claims up to £250,000. The scheme was due to come into force on 1 October.
But health minister Ben Gummer confirmed that the implementation would not go ahead as planned and that a consultation will be published later in the year.
Chair of the Bar reflects on 2025
Q&A with criminal barrister Nick Murphy, who moved to New Park Court Chambers on the North Eastern Circuit in search of a better work-life balance
Revolt Cycling in Holborn, London’s first sustainable fitness studio, invites barristers to join the revolution – turning pedal power into clean energy
Rachel Davenport, Co-founder and Director at AlphaBiolabs, reflects on how the company’s Giving Back ethos continues to make a difference to communities across the UK
By Marie Law, Director of Toxicology at AlphaBiolabs
AlphaBiolabs has made a £500 donation to Sean’s Place, a men’s mental health charity based in Sefton, as part of its ongoing Giving Back initiative
Professor Dominic Regan and Seán Jones KC present their best buys for this holiday season
Little has changed since Burns v Burns . Cohabiting couples deserve better than to be left on the blasted heath with the existing witch’s brew for another four decades, argues Christopher Stirling
Six months of court observation at the Old Bailey: APPEAL’s Dr Nisha Waller and Tehreem Sultan report their findings on prosecution practices under joint enterprise
Despite its prevalence, autism spectrum disorder remains poorly understood in the criminal justice system. Does Alex Henry’s joint enterprise conviction expose the need to audit prisons? asks Dr Felicity Gerry KC
With automation now deeply embedded in the Department for Work Pensions, Alexander McColl and Alexa Thompson review what we know, what we don’t and avenues for legal challenge
